For Biotech

If a clinician asks ChatGPT about your trial, will the model cite the right endpoints?

Phase II readouts get summarized by LLMs within hours. AI-native structure controls how those summaries get framed.

The pain
  • Trial readouts misquoted in AI summaries
  • Generic NewsArticle schema obscuring primary endpoints
  • Wire-only distribution missing the medical-research corpus
The plays

MedicalCondition + Drug schema

Structured data for indication, mechanism, endpoints, and trial registry IDs.

Atomic results

Each endpoint result as a discrete, citeable claim with confidence intervals.

ClinicalTrial linking

Bidirectional links to ClinicalTrials.gov and EU CTR records.

Built by High Caliber AI

We do this for brands. Want us to do it for yours?

We help biotechs translate trial communications into the format LLMs and answer engines actually parse.